Skip to Content

Vincristine Sulfate Injection

Last Updated: January 31, 2020
Status: Resolved

Reason for the Shortage
    • Pfizer had vincristine on shortage due to manufacturing delays and increased demand. They are the sole supplier of vincristine sulfate injection. There is a Dear Healthcare Professional letter available at https://www.fda.gov/media/131865/download.
    • Teva discontinued Vincosar in early-July 2019.
Available Products
    • Vincristine injection, Pfizer, 1 mg/mL, 1 mL vial, 1 count, NDC 61703-0309-06
    • Vincristine injection, Pfizer, 1 mg/mL, 2 mL vial, 1 count, NDC 61703-0309-16

Estimated Resupply Dates

    • Pfizer has vincristine 1 mg/mL 1 mL and 2 mL vials available.

Updated

Updated January 31, 2020 by Michelle Wheeler, PharmD, Drug Information Specialist. Created October 1, 2019 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2020, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.